These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 16523930)

  • 1. [Lupus nephritis: Pathogenesis, pathophysiology, and therapy].
    Yamada A
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():442-5. PubMed ID: 16523930
    [No Abstract]   [Full Text] [Related]  

  • 2. [TNF family (TNF alpha, beta, FasL, CD40L)].
    Manago S; Yonehara S
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():202-6. PubMed ID: 15861657
    [No Abstract]   [Full Text] [Related]  

  • 3. A family of ligands for the TNF receptor superfamily.
    Cosman D
    Stem Cells; 1994 Sep; 12(5):440-55. PubMed ID: 7528588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FasL/Fas and TNF/TNFR interactions in the regulation of immune responses and disease.
    Lynch DH; Campbell KA; Miller RE; Badley AD; Paya CV
    Behring Inst Mitt; 1996 Oct; (97):175-84. PubMed ID: 8950475
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF.
    Grell M; Zimmermann G; Gottfried E; Chen CM; Grünwald U; Huang DC; Wu Lee YH; Dürkop H; Engelmann H; Scheurich P; Wajant H; Strasser A
    EMBO J; 1999 Jun; 18(11):3034-43. PubMed ID: 10357816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dual role for both CD40-ligand and TNF-alpha in controlling human B cell death.
    Lens SM; Tesselaar K; den Drijver BF; van Oers MH; van Lier RA
    J Immunol; 1996 Jan; 156(2):507-14. PubMed ID: 8543800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular requirements for CD8-mediated rejection of a MUC1-expressing pancreatic carcinoma: implications for tumor vaccines.
    Sivinski CL; Kohlgraf KG; VanLith ML; Morikane K; Tempero RM; Hollingsworth MA
    Cancer Immunol Immunother; 2002 Aug; 51(6):327-40. PubMed ID: 12111121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
    Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tumor necrosis factor ligand and receptor families.
    Bazzoni F; Beutler B
    N Engl J Med; 1996 Jun; 334(26):1717-25. PubMed ID: 8637518
    [No Abstract]   [Full Text] [Related]  

  • 11. Co-stimulatory agonists as immunological adjuvants.
    Barr TA; Carlring J; Heath AW
    Vaccine; 2006 Apr; 24(17):3399-407. PubMed ID: 16530301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells.
    Akiba H; Oshima H; Takeda K; Atsuta M; Nakano H; Nakajima A; Nohara C; Yagita H; Okumura K
    J Immunol; 1999 Jun; 162(12):7058-66. PubMed ID: 10358148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of Fas mediated apoptosis in preeclampsia.
    Neale DM; Mor G
    J Perinat Med; 2005; 33(6):471-7. PubMed ID: 16318609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems.
    Walczak H; Krammer PH
    Exp Cell Res; 2000 Apr; 256(1):58-66. PubMed ID: 10739652
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of apoptosis in mature T cells by tumour necrosis factor.
    Zheng L; Fisher G; Miller RE; Peschon J; Lynch DH; Lenardo MJ
    Nature; 1995 Sep; 377(6547):348-51. PubMed ID: 7566090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular signaling in death receptor and mitochondrial pathways of apoptosis (Review).
    Gupta S
    Int J Oncol; 2003 Jan; 22(1):15-20. PubMed ID: 12469180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fas (CD95)-related apoptosis and rheumatoid arthritis.
    Peng SL
    Rheumatology (Oxford); 2006 Jan; 45(1):26-30. PubMed ID: 16159946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromal derived factor-1 alpha (SDF-1 alpha) induces CD4+ T cell apoptosis via the functional up-regulation of the Fas (CD95)/Fas ligand (CD95L) pathway.
    Colamussi ML; Secchiero P; Gonelli A; Marchisio M; Zauli G; Capitani S
    J Leukoc Biol; 2001 Feb; 69(2):263-70. PubMed ID: 11272277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoamplification of apoptosis following ligation of CD95-L, TRAIL and TNF-alpha.
    Herr I; Posovszky C; Di Marzio LD; Cifone MG; Boehler T; Debatin KM
    Oncogene; 2000 Aug; 19(37):4255-62. PubMed ID: 10980599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation-induced cell death of human T-cell subsets is mediated by Fas and granzyme B but is independent of TNF-alpha.
    Gorak-Stolinska P; Truman JP; Kemeny DM; Noble A
    J Leukoc Biol; 2001 Nov; 70(5):756-66. PubMed ID: 11698496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.